Data availability statement
The data that support the findings of this study are openly available in Clinical Case Reports
References:
  1. Gladdy RA, Wunder JS. Risk-stratified surveillance in dermatofibrosarcoma protuberans: Less is more. Cancer. 2019 Mar 01;125(5):670-672. [PubMed] [Reference list]
  2. Sirvent N, Maire G, Pedeutour F. Genetics of dermatofibrosarcoma protuberans family of tumors: from ring chromosomes to tyrosine kinase inhibitor treatment. Genes Chromosomes Cancer . 2003;37(1):1-19. doi:10.1002/gcc.10202
  3. Rutgers EJT, Kroon BBR, Albus-Lutter CE, et al. Dermatofibrosarcoma protuberans: treatment and prognosis. Eur J Surg Oncol. 1992;18:241–8. [PubMed] [Google Scholar] [Ref list]
  4. Weiss SW, Goldblum JR, editors. Soft tissue tumors.  4th ed. St Louis: Mosby; 2001. Enginger and Weiss S. [Google Scholar] [Ref list]
  5. Hayakawa K, Matsumoto S, Ae K, Tanizawa T, Gokita T, Funauchi Y, Motoi N. Risk factors for distant metastasis of dermatofibrosarcoma protuberans. J Orthop Traumatol. 2016 Sep;17(3):261-6. [PMC free article] [PubMed] [Reference list]
  6. Brooks J, Ramsey ML. Dermatofibrosarcoma Protuberans. [Updated 2022 Jan 21]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK513305/
  7. Shah SR, Regmee S, Maharjan DK, Thapa PB. Recurrent Dermatofibrosarcoma Protuberance: A Case Report. JNMA J Nepal Med Assoc . 2021;59(243):1192-1195. Published 2021 Nov 15. doi:10.31729/jnma.7187
  8. K C, H. B., Shrestha, J. M., & Lohani, I. (2020). Recurrent dermatofibrosarcoma protuberans: A Case report and literature review. Journal of Society of Surgeons of Nepal23 (2), 67–69. https://doi.org/10.3126/jssn.v23i2.35844
  9. Ghimire, R., Subedi, S., Sharma, A., & Bohara, S. (2016). Anterior abdominal wall dermatofibrosarcoma protuberans: a case report. Journal of Society of Surgeons of Nepal17 (1), 39–41. https://doi.org/10.3126/jssn.v17i1.15180